Clinical Trial Update: Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

View source ↗

Summary

A post-marketing safety surveillance study evaluating the Synflorix pneumococcal vaccine in Korean infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Streptococcal Infections

Drugs mentioned

• Synflorix (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Status: COMPLETED